After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing. In an interview with Wired, R3 listed three investors: billionaire Tim Draper, the Singapore-based fund Immortal…
For over thirty years, I have led a successful media production and communication consulting company. Only 25% of new businesses survive for 15 years or more, so I have beat the odds. But having staying power is not a matter of luck.